Headquarters
295 WASHINGTON AVE, HAMDEN, CT 06518-3025, US
HAMDEN, CT, US
CAROGEN CORP
From the company
CaroGen Corporation is a Yale School of Medicine spin-out based in Farmington, Connecticut, developing a functional cure for chronic hepatitis B. Its lead candidate CARG-201 is a replicating RNA immunotherapy built on the AVIDIO™ virus-like vesicle (VLV) platform, currently advancing through Phase 1/1b under IND 31717. The company holds U.S. Patent No. 12,577,585 and has received ~$11.0M in NIH and DoD grants.
Products & services offered
Capabilities 4
Classifications
- Ownership classifications (3)
- Black American Owned, Minority Owned Business, Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.